Results :
155 type 2 DM patients were included in the study. In 64 patients (41%) there were more than 5 white dots in the central fundus. We found no significant difference in pRNFL , mGCL or mIRL thickness between type 2 DM patients with or without white dots in the central fundus.Mean pRNFL thickness was 96±12 vs. 96±13 (p=0.619), mean mGCL thickness 45±8 vs. 45±8 (p=0.787) and mean mIRL thickness 107±12 vs. 109±13 (p=0.212).No significant difference was found between type 2 DM patients with or without white dots in the presence of minimal DR (p=0.61) and levels of HbA1c, creatinine and lipid profile.

Conclusions :
White dots in the ocular fundus of type 2 DM patients do not have a relation with neuroretinal degeneration measured with SD-OCT, nor with the presence of DR or metabolic control.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.